ArticleBMC microbiology2025
Isolation and characterization of an antibiofilm bacteriophage against Klebsiella michiganensis and evaluation of its therapeutic potential in an insect larval gut colonization model.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Genomic and virulence characterization of OXA-48-producingFrontiers in microbiology · 2026Article
- Article
- Characterization of a lytic Salmonella phage GF04 within theFrontiers in microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBacteriophages (phages) have therapeutic potential against AMR bacteria. Recently, Klebsiella michiganensis (a member of the Klebsiella oxytoca complex) was discovered. This pathogen is associated with nosocomial infection and sepsis and has the ability to neutralize the β-lactam class of antibiotics. This study focused on detailed characterization of the phage vB_KleM_kp20 (kp20) and evaluation of its in vitro and in vivo efficacy against K. michiganensis.
methodsPhage kp20 was isolated from sewage water, purified, and characterized via standard methods, including adsorption assay, one-step growth curve, host range determination, pH/temperature stability, in vitro lysis kinetics, transmission electron microscopy (TEM), and genome sequencing. The therapeutic potential of kp20 was also evaluated through in vitro antibiofilm activity and in vivo decolonization in a mosquito larval model (Aedes albopictus).
resultskp20 showed narrow host specificity, a rapid adsorption rate (> 60% adsorption within 10 min), a short latency period (~ 10 min), a large burst size (~ 100 PFU per infected cell), and strong in vitro antibacterial activity at a low MOI (0.1). Phage kp20 retained infectivity over a range of temperatures (4–40 °C) and pH values (6–10). In the in vitro antibiofilm assay, a 39% reduction in biomass was observed at an MOI of 1. Transmission electron micrography revealed a myovirus morphology, and genetic analyses revealed an ~ 174 kb dsDNA genome (GenBank PP993148) harboring at least 267 CDSs and 2 tRNA genes. No AMR/toxin- or integration-related genes were detected. Analyses of the proteomic tree revealed the affinity of kp20 for the genus Slopekvirus under the Straboviridae family of viruses. Compared with no treatment, treatment with kp20 significantly reduced survival (70% vs. 40%; P < 0.001) and growth (2.1 ± 0.38 mm vs. 1.4 ± 0.17 mm; p < 0.0001) in the mosquito larval gut colonization model.
conclusionThe results of our study suggest promising therapeutic potential for phage kp20. Furthermore, we demonstrated that the mosquito larval gut colonization model could be utilized as a convenient pre-murine model to evaluate phage efficacy in vivo.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.